SearchDictionaryMobileLogin

Can very high-dose anti-tumor necrosis factor blockade at onset of rheumatoid arthritis produce long-term remission?

AuthorsPhilip G Conaghan, Mark A Quinn, Philip O'Connor, Richard J Wakefield, Zunaid Karim, Paul Emery
JournalArthritis and rheumatism (Arthritis Rheum) Vol. 46 Issue 7 Pg. 1971-2; author reply 1973 (Jul 2002) ISSN: 0004-3591 United States
PMID12124886 (Publication Type: Comment, Letter)
Chemical References
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • infliximab
  • Methotrexate
Topics
  • Antibodies, Monoclonal (administration & dosage)
  • Antirheumatic Agents (administration & dosage)
  • Arthritis, Rheumatoid (diagnosis, drug therapy)
  • Drug Therapy, Combination
  • Humans
  • Methotrexate (administration & dosage)
  • Pilot Projects
  • Remission Induction
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)